These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 230854)

  • 41. Neoplastic transformation of rabbit cells by murine sarcoma viruses.
    Rhim JS; Bedigian HG; Fox RR
    Int J Cancer; 1982 Sep; 30(3):365-9. PubMed ID: 7129681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transformation of cultured rat adrenocortical cells by Kirsten murine sarcoma virus (Ki-MSV).
    Auersperg N; Hudson JB; Goddard EG; Klement V
    Int J Cancer; 1977 Jan; 19(1):81-9. PubMed ID: 188772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

  • 44. Characterization of the presumptive sarcoma cells in primary MSV tumors.
    Becker S; Haskill S
    Int J Cancer; 1980 Apr; 25(4):543-50. PubMed ID: 6989765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic efficacy of repeated cycles of local IL-2 injections in mice carrying slowly growing tumour grafts.
    Símová J; Bubeník J; Indrová M; Bubeníková D; Jandlová T
    Folia Biol (Praha); 1993; 39(6):315-22. PubMed ID: 7926162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T-cell immunity to murine Moloney sarcoma virus-induced tumours: L3T4+ T cells are necessary for resistance to primary sarcoma growth, but Lyt-2+ T cells are required for resistance to secondary tumour cell challenge.
    Bateman WJ; Jenkinson EJ; Owen JJ
    Immunology; 1987 Jul; 61(3):317-20. PubMed ID: 2956180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of vitamin B-6 deficiency on host susceptibility to Moloney sarcoma virus-induced tumor growth in mice.
    Ha C; Kerkvliet NI; Miller LT
    J Nutr; 1984 May; 114(5):938-48. PubMed ID: 6726463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW; Powell TJ; Walia AS; Lidin BI; Srinivas RV; Baskin JG; Kearney JF
    J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Moloney sarcoma virus-induced tumors in athymic (nude) mice: growth pattern and antibody responses.
    Davis S
    J Natl Cancer Inst; 1975 Mar; 54(3):793-4. PubMed ID: 164570
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.
    Epstein LB; Knight RA
    Br J Cancer; 1975 May; 31(5):499-512. PubMed ID: 50852
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-mediated immunity to moloney sarcoma virus in mice. I. Analysis of antigens responsible for lymphocyte stimulation in regressor mice.
    Knight RA; Gorczynski RM
    Int J Cancer; 1975 Jan; 15(1):48-58. PubMed ID: 47841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcoma-negative leukemia-positive transformed cell culture established from a murine sarcoma virus-induced rat bone tumor.
    Chan JC; East JL; Dmochowski L
    Cancer Res; 1975 Sep; 35(9):2475-81. PubMed ID: 167960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M; Pearson G; Redmon L; Winters E; Kasuga S
    J Immunol; 1975 Apr; 114(4):1318-22. PubMed ID: 1090675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lactate dehydrogenase-elevating virus induces antibodies reactive with a surface antigen of aetiologically unrelated murine cell transformants.
    Weiland E; Grossmann A; Thiel HJ; Weiland F
    J Gen Virol; 1990 May; 71 ( Pt 5)():1233-6. PubMed ID: 2345370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Moloney murine sarcoma virus 349 induces Kaposi's sarcomalike lesions in Balb/c mice.
    Stoica G; Hoffman J; Yuen PH
    Am J Pathol; 1990 Apr; 136(4):933-47. PubMed ID: 2158239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo growth and antigenic properties of a rat sarcoma induced by Moloney sarcoma virus.
    Jones JM; Jensen F; Veit B; Feldman JD
    J Natl Cancer Inst; 1974 Jun; 52(6):1771-7. PubMed ID: 4134500
    [No Abstract]   [Full Text] [Related]  

  • 58. Growth of murine sarcoma and murine xenotropic leukemia viruses in Japanese quail: induction of tumors and development of continuous tumor cell lines.
    Robey WG; Kuenzel WJ; Vande Woude GF; Fischinger PJ
    Cancer Res; 1982 Jul; 42(7):2523-9. PubMed ID: 6282443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two levels of restriction by mouse or cat cells of murine sarcoma virus coated by endogenous xenotropic oncornavirus.
    Fischinger PJ; Nomura S; Blevins CS; Bolognesi DP
    J Gen Virol; 1975 Oct; 29(1):51-62. PubMed ID: 171336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C; Debré P; Leclerc JC
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.